Clinical trial of kunzea oil for onychomycoses treatment-commercial potential

University of Tasmania

  • Project code: PRJ-000464

  • Project stage: Closed

  • Project start date: Friday, September 1, 2006

  • Project completion date: Wednesday, July 29, 2009

  • National Priority: NEPI-Feasibility studies and industry literature reviews

Summary

This study will compare the effectiveness and tolerability of kunzea oil with amorolfine nail lacquer in the treatment of onychomycosis. Our hypothesis is that due its potent antifungal activity and high penetration of the nail bed kunzea oil is a better treatment for onychomycosis than amorolfine. The proposed trial of the oil will result in the clinical validation of the oil for the treatment onychomycosis. Clinical proof of efficacy can then be used in the marketing of the oil as a therapeutic agent. Industry and commercial partners will facilitate commercialisation of this product should clinical efficacy be demonstrated.

Program

New and Emerging Plant Industries

Research Organisation

University of Tasmania

Objective Summary

This study will compare the effectiveness and tolerability of kunzea oil with amorolfine nail lacquer in the treatment of onychomycosis. Our hypothesis is that due its potent antifungal activity and high penetration of the nail bed kunzea oil is a better treatment for onychomycosis than amorolfine. The proposed trial of the oil will result in the clinical validation of the oil for the treatment onychomycosis. Clinical proof of efficacy can then be used in the marketing of the oil as a therapeutic agent. Industry and commercial partners will facilitate commercialisation of this product should clinical efficacy be demonstrated.